Indication
Alpha-mannosidosis
Alpha-mannosidosis is an ultra-rare, inherited lysosomal storage disorder caused by pathogenic variants in the *MAN2B1* gene, resulting in a deficiency of the enzyme lysosomal alpha-mannosidase. Read more about Alpha-mannosidosis
1 drugs 1 manufacturers
Drugs that treat it
Common Alpha-mannosidosis therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAlpha-mannosidosis is an ultra-rare, inherited lysosomal storage disorder caused by pathogenic variants in the *MAN2B1* gene, resulting in a deficiency of the enzyme lysosomal alpha-mannosidase.
This enzymatic deficit leads to progressive, pathologic accumulation of mannose-rich oligosaccharides across tissues and organ systems.
Primarily presenting in pediatric patients and persisting into adulthood, the condition exhibits a spectrum of severity that can involve intellectual disability, sensorineural hearing loss, dysmorphic facial features, skeletal abnormalities (dysostosis multiplex), motor dysfunction, and immune deficiency with recurrent infections.
- nih.gov
Alpha-mannosidosis is an ultra-rare, inherited lysosomal storage disorder caused by pathogenic variants in the *MAN2B1* gene, resulting in a deficiency of the enzyme lysosomal alpha-mannosidase
- rarediseases.org
Alpha-mannosidosis is an ultra-rare, inherited lysosomal storage disorder caused by pathogenic variants in the *MAN2B1* gene, resulting in a deficiency of the enzyme lysosomal alpha-mannosidase
- nih.gov
Alpha-mannosidosis is an ultra-rare, inherited lysosomal storage disorder caused by pathogenic variants in the *MAN2B1* gene, resulting in a deficiency of the enzyme lysosomal alpha-mannosidase This enzymatic deficit leads to progressive, pathologic accumulation of mannose-rich oligosaccharides across tissues and organ systems Primarily presenting in pediatric patients and persisting into adulthood, the condition exhibits a spectrum of severity that can involve intellectual disability, sensorine...
- medlineplus.gov
This enzymatic deficit leads to progressive, pathologic accumulation of mannose-rich oligosaccharides across tissues and organ systems
- nih.gov
Primarily presenting in pediatric patients and persisting into adulthood, the condition exhibits a spectrum of severity that can involve intellectual disability, sensorineural hearing loss, dysmorphic facial features, skeletal abnormalities (dysostosis multiplex), motor dysfunction, and immune deficiency with recurrent infections
- childrenshospital.org
Primarily presenting in pediatric patients and persisting into adulthood, the condition exhibits a spectrum of severity that can involve intellectual disability, sensorineural hearing loss, dysmorphic facial features, skeletal abnormalities (dysostosis multiplex), motor dysfunction, and immune deficiency with recurrent infections
Personalize your experience
Follow Alpha-mannosidosis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.